Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Committee Hears Hours of Testimony on Proposal to Require Medicaid Coverage for GLP‑1 Drugs

House Commerce and Consumer Affairs · April 15, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

A lengthy committee hearing on Senate Bill 455 drew patients, clinicians and the Department of Health and Human Services to debate whether New Hampshire Medicaid should be required to cover GLP‑1 medications for obesity and related conditions; proponents cited clinical benefits and downstream savings while DHHS warned of large near‑term fiscal costs.

Senators and witnesses spent several hours debating Senate Bill 455, which would direct the New Hampshire Department of Health and Human Services to provide coverage for GLP‑1 medications under the state Medicaid plan when medically necessary. Senator Sue Apprentice, who introduced the measure, said the drugs are “clinically proven to reduce body weight by 10 to 20%” and argued that coverage could prevent costly complications such as amputation and dialysis.

The bill’s supporters included physicians, diabetes educators and patient advocates who described dramatic clinical results and urged access for…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans